About Glide Technologies
Glide Technologies is a company based in Abingdon (United Kingdom) founded in 2001.. Glide Technologies has raised $29.15 million across 4 funding rounds from investors including Gov.uk, Oxford Technology and Invesco Perpetual. The company has 22 employees as of September 30, 2016. Glide Technologies operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and HOOKIPA Pharma, among others.
- Headquarter Abingdon, United Kingdom
- Employees 22 as on 30 Sep, 2016
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Glide Pharmaceutical Technologies Limited
-
Annual Revenue
$425.05 K (USD)0as on Jun 30, 2015
-
Net Profit
$-3.34 M (USD)28as on Jun 30, 2016
-
EBITDA
$-4.06 M (USD)28as on Jun 30, 2016
-
Total Equity Funding
$29.15 M (USD)
in 4 rounds
-
Latest Funding Round
$4 M (USD), Series B
Feb 01, 2017
-
Investors
Gov.uk
& 2 more
-
Employee Count
22
as on Sep 30, 2016
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Glide Technologies
Glide Technologies has successfully raised a total of $29.15M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $4 million completed in February 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $4.0M
-
First Round
First Round
(13 Oct 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2017 | Amount | Series B - Glide Technologies | Valuation |
investors |
|
| Feb, 2013 | Amount | Series B - Glide Technologies | Valuation |
investors |
|
| Nov, 2012 | Amount | Grant - Glide Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Glide Technologies
Glide Technologies has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Oxford Technology and Invesco Perpetual. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage micro-VC investments are focused on UK companies.
|
Founded Year | Domain | Location | |
|
Diversified investment management services are provided globally.
|
Founded Year | Domain | Location | |
|
Online government services and information are provided to users.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Glide Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Glide Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glide Technologies Comparisons
Competitors of Glide Technologies
Glide Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and HOOKIPA Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Glide Technologies
When was Glide Technologies founded?
Glide Technologies was founded in 2001 and raised its 1st funding round 7 years after it was founded.
Where is Glide Technologies located?
Glide Technologies is headquartered in Abingdon, United Kingdom. It is registered at Abingdon, Oxfordshire, United Kingdom.
Is Glide Technologies a funded company?
Glide Technologies is a funded company, having raised a total of $29.15M across 4 funding rounds to date. The company's 1st funding round was a Grant of $3.7M, raised on Oct 13, 2008.
How many employees does Glide Technologies have?
As of Sep 30, 2016, the latest employee count at Glide Technologies is 22.
What is the annual revenue of Glide Technologies?
Annual revenue of Glide Technologies is $425.05K as on Jun 30, 2015.
What does Glide Technologies do?
Glide Technologies is a specialty pharmaceutical company developing products for easy, safe and convenient delivery of pharmaceuticals and vaccines on its proprietary Glide SDI - the Solid Dose Injector. The company has a portfolio of 5 pipeline products, all of which are focused on developing a solid dosage formulation of existing drugs for higher stability and better drug delivery.
Who are the top competitors of Glide Technologies?
Glide Technologies's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Glide Technologies's investors?
Glide Technologies has 3 investors. Key investors include Gov.uk, Oxford Technology, and Invesco Perpetual.